Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer’s disease is safe
Scientists are reporting results from a Phase I trial in an area of promising research for Alzheimer’s disease — cellular senescence.
Scientists are reporting results from a Phase I trial in an area of promising research for Alzheimer’s disease — cellular senescence.
Scientists found that a subset of CD8+ T cells in the brain lessens the activation of microglia and limits disease pathology in a model of
Medical researchers have used a 3D human neural cell culture model to show that the exercise-induced muscle hormone, irisin, reduces the level of amyloid beta
Researchers have discovered a new avenue of cell death in Alzheimer’s disease and vascular dementia. The study reveals for the first time that a form
A study of twins shows that having a concussion early in life is tied to having lower scores on tests of thinking and memory skills